Gemcitabine in breast cancer: Future directions

Clinical Breast Cancer

Volumn 3, Issue SUPPL. 1, 2002, Pages

  Tripathy, Debu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2 ; 2 Difluorodeoxycytidine; Anthracyclines; Pemetrexed; Taxanes; Trastuzumab; Vinorelbine

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CAPECITABINE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; FOLIC ACID ANTAGONIST; GEMCITABINE; NAVELBINE; PACLITAXEL; PEMETREXED; TAXANE DERIVATIVE; TRASTUZUMAB;

ADVANCED CANCER; ARTICLE; BIOLOGICAL THERAPY; BREAST CANCER; BREAST METASTASIS; CANCER SURVIVAL; CONTROLLED STUDY; DNA STRAND BREAKAGE; DNA SYNTHESIS; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG TARGETING; DRUG TOLERABILITY; FEMALE; HUMAN; QUALITY OF LIFE; RNA SYNTHESIS; STANDARD;

EID: 0036078606     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2002.s.010     Document Type: Article

References (17)

1. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines
2. Overview: Gemcitabine as single-agent therapy for advanced breast cancer
3. Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
4. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers
5. Phase II trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: Preliminary results
6. Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer
7. New cytotoxic agents and schedules for advanced breast cancer
8. Gemcitabine/anthracycline combinations in metastatic breast cancer
9. Neoadjuvant gemcitabine therapy for breast cancer
10. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
11. The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancer
12. Biweekly gemcitabine, doxorubicin, and paclitaxel as first-line treatment in metastatic breast cancer. Final results from a phase II trial
13. Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer
14. Xeloda (capecitabine) plus docetaxel combination therapy in locally advanced/metastatic breast cancer: Latest results
15. Pemetrexed (ALIMTA®) and gemcitabine in breast cancer patients previousy treated with anthracyclines and taxanes
16. Cytotoxic and hormonal treatment for metastatic breast cancer: A systematic review of published randomized trials involving 31,510 women
17. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2